Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to determine the safety and effectiveness of viramidine to
ribavirin in chronic hepatitis C patients who have never before recieved treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.